GlassScriptPhysician profile
Shirling Tsai
NPI 1821242249
$1,140.04
in general payments reported to CMS, 2019-2025
9 companies · $48.58 in 2025
The $48.58 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.85 · 2020: $144 · 2022: $486 · 2023: $151 · 2024: $242 · 2025: $48.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $418.52 | 2020-2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $231.20 | 2022-2025 | In.Pact Admiral |
| Silk Road Medical, INC. | $151.22 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Cook Medical LLC | $110.50 | 2024 | Zilver Ptx |
| Boston Scientific Corporation | $68.85 | 2019 | |
| Cardiovascular Systems INC. | $64.13 | 2022 | |
| Bard Peripheral Vascular, INC. | $61.66 | 2022 | |
| Surmodics, INC. | $33.96 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirling Tsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.